These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 377943)

  • 1. Correlations of immunologic markers with histologic features of human non-Hodgkin's lymphomas.
    Brubaker DB; Whiteside TL; Hartsock RJ
    Am J Clin Pathol; 1979 Jun; 71(6):651-64. PubMed ID: 377943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation between benign and malignant human lymph nodes by means of immunologic markers.
    Brubaker DB; Whiteside TL
    Cancer; 1979 Apr; 43(4):1165-76. PubMed ID: 376086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant lymphomas of follicular center cell origin in man. I. Immunologic studies.
    Leech JH; Glick AD; Waldron JA; Flexner JM; Horn RG; Collins RD
    J Natl Cancer Inst; 1975 Jan; 54(1):11-21. PubMed ID: 1089792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic markers of non-Hodgkin's lymphomas.
    Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
    Recent Results Cancer Res; 1978; 64():138-45. PubMed ID: 366692
    [No Abstract]   [Full Text] [Related]  

  • 6. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
    Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
    Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of intracellular and cell surface immunoglobulin in non-Hodgkin's lymphoma.
    Davey FR; Halliday D; Marucci AA; Gottlieb AJ
    Hum Pathol; 1978 May; 9(3):285-94. PubMed ID: 350755
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the presence of surface localized immunoglobulin (Ig) and the histological type of human malignant lymphomas.
    Johansson B; Klein E; Haglund S
    Clin Immunol Immunopathol; 1976 Jan; 5(1):119-32. PubMed ID: 816584
    [No Abstract]   [Full Text] [Related]  

  • 10. Immune marker expression in 53 lymphomas of high-grade malignancy.
    Pallesen G; Madsen M; Schifter S
    Histopathology; 1983 Nov; 7(6):841-57. PubMed ID: 6689315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoelectric focusing pattern of IgM and surface markers in non-Hodgkin's lymphomas.
    Stein H; Bouman H; Lennert K; Fuchs J; Havsteen B
    Haematol Blood Transfus; 1977; 20():315-27. PubMed ID: 344162
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocyte surface characteristics in malignant lymphoma.
    Aisenberg AC; Long JC
    Am J Med; 1975 Mar; 58(3):300-6. PubMed ID: 1090157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic surface markers in non-Hodgkin's lymphomas.
    Cossman J; Schnitzer B; Deegan MJ
    Am J Pathol; 1977 Apr; 87(1):19-32. PubMed ID: 322504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of histologic and immunologic heterogeneity of non-Hodgkin's lymphomas.
    Borowitz MJ; Croker BP; Metzgar RS
    Am J Pathol; 1981 Nov; 105(2):97-106. PubMed ID: 6170233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine malignant lymphomas: comparison of morphologic and immunologic parameters.
    Holmberg CA; Manning JS; Osburn BI
    J Natl Cancer Inst; 1976 Jan; 56(1):125-35. PubMed ID: 768497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic and cytochemical properties of histiocytic and mixed histiocytic-lymphocytic lymphomas.
    Morris MW; Davey FR
    Am J Clin Pathol; 1975 Mar; 63(3):403-14. PubMed ID: 46698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell-rich lymphoproliferative disorders. Morphologic and immunologic differential diagnoses.
    Winberg CD; Sheibani K; Burke JS; Wu A; Rappaport H
    Cancer; 1988 Oct; 62(8):1539-55. PubMed ID: 2901904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic aspects and pathology of the malignant lymphomas.
    Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
    Cancer; 1978 Aug; 42(2 Suppl):911-21. PubMed ID: 356957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.